9025U |
Ethyl Sulfate Screen, Urine |
9103U |
Alfentanil Screen, Urine |
9109U |
Atropine Screen, Urine |
9122U |
Bupropion and Metabolite Screen, Urine |
9139U |
Clonazepam and Metabolite Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9146UC |
Ethyl Glucuronide Screen, Umbilical Cord Tissue |
9193U |
Methylphenidate and Metabolite Screen, Urine |
9205U |
Dextro / Levo Methorphan Screen - Total, Urine |
9206U |
Dextrorphan / Levorphanol Screen - Total, Urine |
9237U |
Phenylpropanolamine Screen, Urine |
9248U |
Pseudoephedrine Screen, Urine |
9249U |
Pseudoephedrine vs Ephedrine Differentiation Screen, Urine |
9261U |
Scopolamine Screen, Urine |
9264U |
Sufentanil Screen, Urine |
9306U |
Anabolic Steroids Screen, Urine |
9318U |
Diuretics Screen, Urine |
9329U |
Benzodiazepines Panel, Urine |
9341U |
Flunitrazepam and Metabolites Screen, Urine |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9404U |
Nicotine and Metabolite with Anabasine Screen, Urine |
9447U |
Venlafaxine and Metabolite Screen, Urine |
9562U |
Synthetic Cannabinoid Metabolites Screen - Expanded, Urine |